Tissue transglutaminase mRNA expression in apoptotic cell death

Apoptosis

Volumn 8, Issue 6, 2003, Pages 673-679

  Volokhina, E B ^a   Hulshof, R ^a   Haanen, C ^a   Vermes, I ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Apoptosis; Cultured cells; Mononuclear cells; Myelodysplastic syndrome; Necrosis; Real time RT PCR; Tissue transglutaminase mRNA expression

Indexed keywords

BIOCHEMICAL MARKER; CELL PROTEIN; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ACCURACY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

APOPTOSIS; FEMALE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED;

EUKARYOTA;

EID: 0242551421     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026160231564     Document Type: Article

References (32)

1. Cotter TG, Martin SJ, eds. Techniques in Apoptosis: A User's Guide. London: Portland Press, 1996.
2. Darzynkiewicz Z, Li X. Measurement of cell death by flow cytometry. In: Cotter TG, Martin SJ, eds. Techniques in Apoptosis, A User's Guide. London: Portland Press, 1996: 71-106.
3. Vermes I, Haanen C, Reutelingsperger CPM. Molecular biology of apoptosis and programmed cell death. In: Aruoma OI, Halliwell B, eds. Molecular Biology of Free Radicals in Human Diseases. London: OICA International, Saint Lucia, 1998: 225-286.
4. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Meth 2000; 243: 167-190.
5. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int J Oncol 2003; 22: 15-20.
6. Kroemer G, Zanzimi N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
7. Nicoletti I, Migliorati G, Pagliacci MC, Grinani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 1991; 139: 271-279.
8. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
9. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53: 1945-1951.
10. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.
11. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: An historical perspective. In: Tomei LD, Cope FO, eds. Apoptosis, the Molecular Basis of Cell Death. Cold Spring Harbor, NY (USA): Cold Spring Harbor Laboratory Press, 1991: 5-29.
12. Fesus L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 1987; 224: 104-108.
13. Piacentini M, Autuori P. Immunohistochemical localization of tissue transglutaminase and Bcl-2 in rat uterine tissues during embryo implantation and post-partum involution. Differentiation 1994; 57: 51-61.
14. Aeschkimann D, Koeller MK, Allen-Hoffmann BL, Mosher DF. Isolation of cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse trascription-polymearase chain reaction with degenerate primers. J Biol Chem 1998; 273: 452-560.
15. Melino G, Candi E, Steinert PM. Assays for transglutaminases in cell death. Methods Enzymol 2000; 322: 433-472.
16. Folk JE, Chung SI. Transglutaminase. Methods Enzymol 1985; 113: 358-375.
17. Lajeml M, Demignot S, Adolphe M. Detection and characterization, using fluoresceincadaverine, of amino acceptor substrates accessible to active transglutaminase expressed by rabbit articular chondrocytes. Histochem J 1998; 30: 499-508.
18. Nemes Z, Madl A, Marekov LN, Piacentini M, Steinert PM, Fesus L. Analysis of protein transglutamination in apoptosis. Methods Cell Biol 2001; 66: 111-133.
19. Grabarek J, Ardelt B, Kunicki J, Darzynkiewicz Z. Detection of in situ activation of transglutaminase during apoptosis: Correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry. Cytometry 2002; 49: 83-89.
20. Fesus L, Piacentini M. Transglutaminas 2: An enigmatic enzyme with diverse functions. Trends Biochem Sci 2002; 27: 534-539.
21. Melino G, Piacentini M. Tissue transglutaminase in cell death: A downstream or a multifunctional upstream effector? FEBS Lett 1998; 430: 59-63.
22. Piredda L, Amendola A, Colizzi V, et al. Lack of "tissue" transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: Relationship to development of autoimmunity in MRL lpr/lpr mice. Cell Death Differentiation 1997; 4: 463-472.
23. Amendola A, Fesus L, Piaentini M, Szondy Z. "Tissue" transglutaminase in AIDS. J Immunol Meth 2002; 265: 145-159.
24. Sárvári M, Fésus L, Nemes Z. Transgluaminase-mediated crosslinking of neural proteins in Alzheimer's disease and other primary dementias. Drug Development Research 2002; 56: 458-472.
25. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clinical Invest 1973; 52: 2745-2756.
26. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-994.
27. Fesus L, Madi A, Balajthy Z, Nemes Z, Szondy Z. Transglutaminase induction by various cell death and apoptosis pathways. Exprientia 1996; 52: 942-949.
28. Fesus L, Thomazy V, Autuori F, Ceru MP, Tarcsa E, Piacentini M. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett 1989; 245: 150-154.
29. Fesus L, Davies PJA, Piacentini M. Apoptosis: Molecular mechanisma in programmed cell death. Eur J Cell Biol 1991; 56: 170-177.
30. Emura I. High incidence of apoptosis in peripheral blood of myelodysplastic syndrome patients determined by Papanicolaou-stained preparations. Lab Hematol 2003; 9: 42-46.
31. Bennett JM, Kouides PA, Forman SJ. The myelodysplastic syndromes: Morphology, risk assessment,and clinical management. Int J Hematol 2002; 76(Suppl 2): 228-238.
32. Raza A, Mundle S, Iftikhar A, et al. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995; 48: 143-154.